恶性肿瘤的早期诊断是目前有待研究解决的课题。用极谱仪测定血清“蛋白接触波”作为肿瘤诊断与疗效观察的指标,在国外应用已有四十余年历史,阳性率70—93.5%。在国内,此方法在临床应用尚少。1964年我院曾对146例各期宫颈癌患者的血清进行极谱测定,总阳性率73—76%,用此法观察50例患者的疗效及20例予后追踪,结果表明, The early diagnosis of malignant tumors is currently the subject of research and solution. The use of polarographic spectrometry to measure serum “protein contact wave” as an indicator of tumor diagnosis and curative effect observation has been applied in foreign countries for more than 40 years, with a positive rate of 70-93.5%. In China, there are few clinical applications of this method. In 1964, the sera of 146 patients with cervical cancer in each stage were measured by polarography. The total positive rate was 73% to 76%. The efficacy of 50 patients and 20 cases were followed up. The results showed that